Share your videos with the world

Valdoxan®/Thymanax® (agomelatine) is more efficacious than both conventional selective serotonin reuptake inhibitor (SSRI) and serotonin noradrenaline reuptake inhibitor (SNRI) antidepressants, according to new data presented today at the 23rd European College of Neuropsychopharmacology (ECNP) Congress. To view Multimedia News Release, go to http://maultivu.prnewswire.com/mnr/prne/valdoxan/44196/